1st International Rare and Paediatric Disease Conference - Virtual Event 18-19/11/2021

Platinum Partner

About Takeda Pharmaceutical Company

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare in approximately 80 countries.

For more information, www.takeda.com

Gold Partner

For more information, www.pfizer.gr

Silver Partner

Ardius Pharma is a company specialized in consulting, planning, designing & executing strategies to support research and market entry of rare disease medications in Greece and Cyprus.

For more information, www.ardiuspharma.com

 

 

 

For more information regarding the Exhibition & Sponsorship during the conference, please contact the Conference Secretariat as follows:

 

Professional Congress Organizer (PCO)

AFEA S.A. Travel & Congress Services
39-41 Lykavittou Street
10672 Athens, Greece
Tel:+30 2103668853
Fax: +30 2103643511
email: [email protected] 

 

Important Dates

Conference Dates: 18-19/11/2021

Follow us on